WO2012013505A2 - Composition - Google Patents

Composition Download PDF

Info

Publication number
WO2012013505A2
WO2012013505A2 PCT/EP2011/062008 EP2011062008W WO2012013505A2 WO 2012013505 A2 WO2012013505 A2 WO 2012013505A2 EP 2011062008 W EP2011062008 W EP 2011062008W WO 2012013505 A2 WO2012013505 A2 WO 2012013505A2
Authority
WO
WIPO (PCT)
Prior art keywords
oxalysine
composition
materials
weight
compositions
Prior art date
Application number
PCT/EP2011/062008
Other languages
French (fr)
Other versions
WO2012013505A3 (en
Inventor
Alexander Gordon James
David William Thornthwaite
Original Assignee
Unilever Plc
Unilever N.V.
Hindustan Unilever Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V., Hindustan Unilever Limited filed Critical Unilever Plc
Publication of WO2012013505A2 publication Critical patent/WO2012013505A2/en
Publication of WO2012013505A3 publication Critical patent/WO2012013505A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants

Definitions

  • the present invention relates to a new antimicrobial composition. Despite the prior art there remains a need for further antimicrobial compositions.
  • the present invention provides a composition comprising oxalysine.
  • Oxalysine is commercially available from Aldrich as (S)-(+)-2-Amino-3-(2- aminoethoxy)propanoic acid monohydrochloride (98%), catalogue number 510564. It has an assigned CAS number of: CAS 1 18021 -35-5.
  • the oxalysine is L-4-oxalysine. More preferably, oxalysine is 2-amino- 3-(2- aminoethoxy)propanoicacid.
  • the oxalysine is present at from 0.001 to 1 .5% wt. of the composition, more preferably from 0.1 to 1.0% wt. of the composition and most preferably from 0.3 to 0.6% by wt. of the composition.
  • composition for reducing or preventing malodour comprising an effective antimicrobial amount of oxalysine.
  • compositions of either aspect of the invention may take any form.
  • Example compositions include wax-based sticks, soap-based sticks, compressed powder sticks, roll-on suspensions or solutions, emulsions, gels, creams, squeeze sprays, pump sprays, and aerosols.
  • Each product form contains its own selection of additional components, some essential and some optional.
  • the types of components typical for each of the above product forms may be incorporated in the corresponding compositions of the invention.
  • a carrier material is an essential component of the compositions of the invention. For cosmetic applications, it is essential that the carrier material is cosmetically acceptable.
  • the carrier material may be hydrophobic or hydrophilic, solid or liquid.
  • Preferred carrier materials are liquids, meaning that they are in neither a solid nor a gaseous state and that they are able to flow under gravity at ambient temperature.
  • Particularly preferred carriers materials are selected from the group consisting of liquid silicones and short chain (C2-C6) alcohols, such as ethanol.
  • Liquid silicones are hydrophobic in nature and are frequently known as liquid polyorganosiloxanes. Such materials may be cyclic or linear, examples include Dow Corning silicone fluids 344, 345, 244, 245, 246, 556, and the 200 series; Union Carbide Corporation Silicones 7207 and 7158; and General Electric silicone SF1202.
  • the carrier material comprises a liquid silicone
  • the oxalysine it is common for the oxalysine to be present as a suspension in the carrier material.
  • Short chain (C2-C6) alcohols are often able to dissolve the oxalysine and it is common for said compound to be present in solution when the carrier material comprises such an alcohol.
  • Preferred short chain (C2-C6) alcohols are
  • dipropylene glycol dipropylene glycol, glycerol propylene glycol, butylene glycol, ethanol, propanol, isopropanol, and industrial methylated spirits. Particularly preferred are ethanol and isopropanol, ethanol being the most preferred.
  • a carrier material examples including polyglycol ethers, preferably oligoglycol ethers having only 2 to 5 repeat units.
  • a carrier material that is a non-silicone hydrophobic liquids may be used. Such materials include mineral oils,
  • polystyrene resin hydrogenated polyisobutene, polydecene, paraffins, isoparaffins of at least 10 carbon atoms, aliphatic or aromatic ester oils (e.g. isopropyl myristate, lauryl myristate, isopropyl palmitate, diisopropyl sebecate, diisopropyl adipate, or Cs to C-I 8 alkyl benzoates), and polyglycol ethers, for example polyglycol butanol ethers.
  • aliphatic or aromatic ester oils e.g. isopropyl myristate, lauryl myristate, isopropyl palmitate, diisopropyl sebecate, diisopropyl adipate, or Cs to C-I 8 alkyl benzoates
  • polyglycol ethers for example polyglycol butanol ethers.
  • hydrophilic liquid carrier materials for example water
  • water it is preferred that the pH of the formulation is near to neutral; that is to say, pH 6 to 8.
  • pH 6 to 8 Such pH values give optimum storage stability to the deodorant active and thereby lengthen the useful lifetime of the composition.
  • carrier materials may also be used.
  • the total amount of carrier material employed is preferably at least 5%, more preferably from 30% to 99%, and most preferably from 60% to 98% by weight of the composition, excluding any volatile propellant present.
  • compositions of the invention is a fragrance material.
  • suitable fragrance materials include conventional perfumes, such as perfume oils and also include so-called deo-perfumes, as described in EP 545,556 and other publications. These latter materials may also qualify as additional organic antimicrobial agents.
  • Levels of incorporation are preferably up to 4% by weight, particularly from 0.1 % to 2% by weight, and especially from 0.7% to 1 .7% by weight of a composition. Synergies may exist between the oxalysine and the perfume - highly effective odour control being the result.
  • compositions of the invention comprise a solution of the deodorant active in an organic solvent.
  • solutions are preferably homogeneous, preferably having an absorbance, relative to the solvent, of less than 0.2, especially less than 0.1 (for a 1 cm pathlength at 600 nm) measured using a Pharmacia Biotech Ultrospec 200 Spectrophotometer or similar instrument.
  • Suitable organic solvents for use in this embodiment include the aforementioned short chain (C2-C6) alcohols.
  • organic solvent When organic solvent is present in the composition, it is preferably present at from 30% to 98, more preferably at from 60% to 97% by weight of the composition, excluding any volatile propellant present.
  • the oxalysine In embodiments of the invention in which the oxalysine is suspended in the carrier material, the oxalysine may have superior chemical stability.
  • compositions according to the invention it is preferred that less than 10%, in particular less than 5%, and especially less than 1 % by weight of water is present. Such low levels of water can lead to an enhancement of the
  • Deodorant actives other than oxalysine may also be present in compositions according to the invention.
  • Such materials may be organic anti-microbial agents. Levels of incorporation of such materials are typically from 0.01 % to 3%, in particular from 0.03% to 0.5% by weight of the composition, excluding any volatile propellant also present.
  • Most of the classes of agents commonly used in the art can be utilised, for example quaternary ammonium compounds, like
  • cetyltrimethylammonium salts cetyltrimethylammonium salts; chlorhexidine and salts thereof; and diglycerol monocaprate, diglycerol monolaurate, glycerol monolaurate, and similar materials, as described in "Deodorant Ingredients", S.A.Makin and M.R.Lowry, in
  • More preferred additional deodorant actives are polyhexamethylene biguanide salts; 2,4,4'-trichloro,2'-hydroxy-diphenyl ether (triclosan); and 3,7, 1 1 - trimethyldodeca-2,6, 10-trienol (farnesol).
  • a particularly preferred additional deodorant active is a transition metal chelator, in particular a material having a high binding constant for iron (III); that is to say, a binding constant for iron (III) of greater than 10 15 , preferably greater than 10 20 , and most preferably greater than 10 26 , such materials being described in
  • EP 1 ,248,520 B (Unilever).
  • a particularly preferred material of this class is diethylenetriaminepentaacetic acid (DTPA). Salts of such materials may also be employed.
  • the total amount of transition metal chelator and/or salt thereof is preferably from 0.1 % to 5%, more preferably from 0.2% to 3%, and especially from 0.4% to 2% by weight of the composition.
  • Inorganic anti-microbial agents may also be present as additional deodorant actives. Such materials may also function as anti-perspirant actives.
  • Such materials are astringent metal salts, in particular, aluminium, zirconium and mixed aluminium/zirconium salts, including both inorganic salts, salts with organic anions and complexes.
  • astringent salts include aluminium, zirconium and aluminium/zirconium halides and halohydrate salts, such as chlorohydrates.
  • preferred levels of incorporation are from 0.5% to 60%, particularly from 5% to 30% or 40% and especially from 5% or 10% to 30% or 35% by weight of a composition.
  • Structurants and emulsifiers are further carrier materials that may be employed. Structurants, when employed, are preferably present at from 1 % to 30% by weight of a composition, whilst emulsifiers are preferably present at from 0.1 % to 10% by weight of a composition. Structurants include cellulosic thickeners such as hydroxy propyl cellulose and hydroxy ethyl cellulose, and dibenzylidene sorbitol.
  • Other structurants include sodium stearate, stearyl alcohol, cetyl alcohol, hydrogenated castor oil, synthetic waxes, paraffin waxes, hydroxystearic acid, dibutyl lauroyl glutamide, alkyl silicone waxes, quaternium-18 bentonite, quaternium-18 hectorite, silica, and propylene carbonate.
  • Emulsifiers include steareth-2, steareth-20, steareth-21 , ceteareth-20, glyceryl stearate, cetyl alcohol, cetearyl alcohol, PEG-20 stearate, dimethicone copolyol, and poloxamines.
  • perfume solubilisers desirable in compositions of the invention comprising perfume are perfume solubilisers.
  • perfume solubilisers include PEG-hydrogenated castor oil, available from BASF in the Cremaphor RH and CO ranges, preferably present at up to 1 .5% by weight, more preferably 0.3 to 0.7% by weight.
  • emulsifiers desirable in compositions of the invention are wash-off agents, for example poly(oxyethylene) ethers.
  • Certain sensory modifiers are further desirable components in the compositions of the invention.
  • Such materials are preferably used at a level of up to 20% by weight of a composition.
  • Emollients, humectants, volatile oils, non-volatile oils, and particulate solids which impart lubricity are all suitable classes of sensory modifiers.
  • Examples of such materials include cyclomethicone, dimethicone, dimethiconol, isopropyl myristate, isopropyl palmitate, talc, finely divided silica (e.g. Aerosil 200), polyethylene (eg.
  • Acumist B18 polysaccharides, corn starch, C12-C15 alcohol benzoate, PPG-3 myristyl ether, octyl dodecanol, C7-C14 isoparaffins, di-isopropyl adipate, isosorbide laurate, PPG-14 butyl ether, glycerol, hydrogenated polyisobutene, polydecene, titanium dioxide, phenyl trimethicone, dioctyl adipate, and hexamethyl disiloxane.
  • compositions perform more than one function. Such components are particularly preferred additional ingredients, their use often saving both money and formulation space. Examples of such components include ethanol, isopropyl myristate, and silica. Further additional components that may also be included are colourants and preservatives, for example C1 -C3 alkyl parabens.
  • Aerosol compositions according to the invention generally comprise a volatile propellant.
  • the level of incorporation of the volatile propellant is typically from 30 to 99 parts by weight and particularly from 50 to 95 parts by weight.
  • Non- chlorinated volatile propellant are preferred, in particular liquefied hydrocarbons or halogenated hydrocarbon gases (particularly fluorinated hydrocarbons such as 1 , 1 -difluoroethane and/or 1 -trifluoro-2-fluoroethane) that have a boiling point of below 10°C and especially those with a boiling point below 0°C.
  • liquefied hydrocarbon gases and especially C3 to Ce hydrocarbons, including propane, isopropane, butane, isobutane, pentane and isopentane and mixtures of two or more thereof.
  • Preferred propellants are isobutane, isobutane/isopropane, isobutane/propane and mixtures of isopropane, isobutane and butane.
  • compositions according to the invention may be prepared by suspending or dissolving the active in a cosmetically acceptable carrier material, preferably with sufficient agitation to achieve a homogeneous mixture.
  • a cosmetically acceptable carrier material preferably with sufficient agitation to achieve a homogeneous mixture.
  • the oxalysine is suspended in the carrier material, it is preferred that it is first ground to a mean particle size of less 100 microns.
  • the fragrance material is preferably added to the composition after the oxalysine has been dissolved or suspended in the carrier.
  • oxalysine for the prevention or reduction of malodour.
  • oxalysine as an antimicrobial agent. EXAMPLE Standard 5 & 24hr deodorancy test protocol was conducted.
  • Oxalysine is superior to control with 99% confidence.
  • Oxalysine is superior to control with 95% confidence.

Abstract

Composition comprising oxalysine. Composition for reducing or prevent malodour comprising an effective antimicrobial amount of oxalysine. Use of oxalysine for the prevention or reduction of malodour. Use of oxalysine as an antimicrobial agent

Description

COMPOSITION
The present invention relates to a new antimicrobial composition. Despite the prior art there remains a need for further antimicrobial compositions.
Accordingly, and in a first aspect, the present invention provides a composition comprising oxalysine. Oxalysine is commercially available from Aldrich as (S)-(+)-2-Amino-3-(2- aminoethoxy)propanoic acid monohydrochloride (98%), catalogue number 510564. It has an assigned CAS number of: CAS 1 18021 -35-5.
Preferably, the oxalysine is L-4-oxalysine. More preferably, oxalysine is 2-amino- 3-(2- aminoethoxy)propanoicacid.
Preferably, the oxalysine is present at from 0.001 to 1 .5% wt. of the composition, more preferably from 0.1 to 1.0% wt. of the composition and most preferably from 0.3 to 0.6% by wt. of the composition.
In a second aspect there is provided a composition for reducing or preventing malodour comprising an effective antimicrobial amount of oxalysine.
The compositions of either aspect of the invention may take any form. Example compositions include wax-based sticks, soap-based sticks, compressed powder sticks, roll-on suspensions or solutions, emulsions, gels, creams, squeeze sprays, pump sprays, and aerosols. Each product form contains its own selection of additional components, some essential and some optional. The types of components typical for each of the above product forms may be incorporated in the corresponding compositions of the invention. A carrier material is an essential component of the compositions of the invention. For cosmetic applications, it is essential that the carrier material is cosmetically acceptable. The carrier material may be hydrophobic or hydrophilic, solid or liquid. Preferred carrier materials are liquids, meaning that they are in neither a solid nor a gaseous state and that they are able to flow under gravity at ambient temperature. Particularly preferred carriers materials are selected from the group consisting of liquid silicones and short chain (C2-C6) alcohols, such as ethanol.
References to ambient temperature in this description should be understood to refer to a temperature of about 23°C.
Liquid silicones are hydrophobic in nature and are frequently known as liquid polyorganosiloxanes. Such materials may be cyclic or linear, examples include Dow Corning silicone fluids 344, 345, 244, 245, 246, 556, and the 200 series; Union Carbide Corporation Silicones 7207 and 7158; and General Electric silicone SF1202. When the carrier material comprises a liquid silicone, it is common for the oxalysine to be present as a suspension in the carrier material.
Short chain (C2-C6) alcohols are often able to dissolve the oxalysine and it is common for said compound to be present in solution when the carrier material comprises such an alcohol. Preferred short chain (C2-C6) alcohols are
dipropylene glycol, glycerol propylene glycol, butylene glycol, ethanol, propanol, isopropanol, and industrial methylated spirits. Particularly preferred are ethanol and isopropanol, ethanol being the most preferred.
Alternatively or in addition to a short chain (C2-C6) alcohol, another organic solvent may be used as a carrier material, examples including polyglycol ethers, preferably oligoglycol ethers having only 2 to 5 repeat units. Alternatively or in addition to a silicone oil, a carrier material that is a non-silicone hydrophobic liquids may be used. Such materials include mineral oils,
hydrogenated polyisobutene, polydecene, paraffins, isoparaffins of at least 10 carbon atoms, aliphatic or aromatic ester oils (e.g. isopropyl myristate, lauryl myristate, isopropyl palmitate, diisopropyl sebecate, diisopropyl adipate, or Cs to C-I 8 alkyl benzoates), and polyglycol ethers, for example polyglycol butanol ethers.
Other hydrophilic liquid carrier materials, for example water, may also be employed. When water is employed, it is preferred that the pH of the formulation is near to neutral; that is to say, pH 6 to 8. Such pH values give optimum storage stability to the deodorant active and thereby lengthen the useful lifetime of the composition.
Mixtures of carrier materials may also be used. The total amount of carrier material employed is preferably at least 5%, more preferably from 30% to 99%, and most preferably from 60% to 98% by weight of the composition, excluding any volatile propellant present.
An essential component of compositions of the invention is a fragrance material. Suitable fragrance materials include conventional perfumes, such as perfume oils and also include so-called deo-perfumes, as described in EP 545,556 and other publications. These latter materials may also qualify as additional organic antimicrobial agents. Levels of incorporation are preferably up to 4% by weight, particularly from 0.1 % to 2% by weight, and especially from 0.7% to 1 .7% by weight of a composition. Synergies may exist between the oxalysine and the perfume - highly effective odour control being the result.
Particular compositions of the invention comprise a solution of the deodorant active in an organic solvent. Such solutions are preferably homogeneous, preferably having an absorbance, relative to the solvent, of less than 0.2, especially less than 0.1 (for a 1 cm pathlength at 600 nm) measured using a Pharmacia Biotech Ultrospec 200 Spectrophotometer or similar instrument.
Suitable organic solvents for use in this embodiment include the aforementioned short chain (C2-C6) alcohols.
When organic solvent is present in the composition, it is preferably present at from 30% to 98, more preferably at from 60% to 97% by weight of the composition, excluding any volatile propellant present. In embodiments of the invention in which the oxalysine is suspended in the carrier material, the oxalysine may have superior chemical stability.
In many compositions according to the invention, it is preferred that less than 10%, in particular less than 5%, and especially less than 1 % by weight of water is present. Such low levels of water can lead to an enhancement of the
performance of the oxalysine, in particular its performance after long term storage of the composition.
Deodorant actives other than oxalysine may also be present in compositions according to the invention. Such materials may be organic anti-microbial agents. Levels of incorporation of such materials are typically from 0.01 % to 3%, in particular from 0.03% to 0.5% by weight of the composition, excluding any volatile propellant also present. Most of the classes of agents commonly used in the art can be utilised, for example quaternary ammonium compounds, like
cetyltrimethylammonium salts; chlorhexidine and salts thereof; and diglycerol monocaprate, diglycerol monolaurate, glycerol monolaurate, and similar materials, as described in "Deodorant Ingredients", S.A.Makin and M.R.Lowry, in
"Antiperspirants and Deodorants", Ed. K. Laden (1999, Marcel Dekker, New York). More preferred additional deodorant actives are polyhexamethylene biguanide salts; 2,4,4'-trichloro,2'-hydroxy-diphenyl ether (triclosan); and 3,7, 1 1 - trimethyldodeca-2,6, 10-trienol (farnesol).
A particularly preferred additional deodorant active is a transition metal chelator, in particular a material having a high binding constant for iron (III); that is to say, a binding constant for iron (III) of greater than 1015, preferably greater than 1020, and most preferably greater than 1026, such materials being described in
EP 1 ,248,520 B (Unilever). A particularly preferred material of this class is diethylenetriaminepentaacetic acid (DTPA). Salts of such materials may also be employed. The total amount of transition metal chelator and/or salt thereof is preferably from 0.1 % to 5%, more preferably from 0.2% to 3%, and especially from 0.4% to 2% by weight of the composition.
Inorganic anti-microbial agents may also be present as additional deodorant actives. Such materials may also function as anti-perspirant actives. Typically, such materials are astringent metal salts, in particular, aluminium, zirconium and mixed aluminium/zirconium salts, including both inorganic salts, salts with organic anions and complexes. Examples of such astringent salts include aluminium, zirconium and aluminium/zirconium halides and halohydrate salts, such as chlorohydrates. When included, preferred levels of incorporation are from 0.5% to 60%, particularly from 5% to 30% or 40% and especially from 5% or 10% to 30% or 35% by weight of a composition.
Structurants and emulsifiers are further carrier materials that may be employed. Structurants, when employed, are preferably present at from 1 % to 30% by weight of a composition, whilst emulsifiers are preferably present at from 0.1 % to 10% by weight of a composition. Structurants include cellulosic thickeners such as hydroxy propyl cellulose and hydroxy ethyl cellulose, and dibenzylidene sorbitol. Other structurants include sodium stearate, stearyl alcohol, cetyl alcohol, hydrogenated castor oil, synthetic waxes, paraffin waxes, hydroxystearic acid, dibutyl lauroyl glutamide, alkyl silicone waxes, quaternium-18 bentonite, quaternium-18 hectorite, silica, and propylene carbonate. Emulsifiers include steareth-2, steareth-20, steareth-21 , ceteareth-20, glyceryl stearate, cetyl alcohol, cetearyl alcohol, PEG-20 stearate, dimethicone copolyol, and poloxamines.
Further emulsifiers desirable in compositions of the invention comprising perfume are perfume solubilisers. Examples include PEG-hydrogenated castor oil, available from BASF in the Cremaphor RH and CO ranges, preferably present at up to 1 .5% by weight, more preferably 0.3 to 0.7% by weight.
Other emulsifiers desirable in compositions of the invention are wash-off agents, for example poly(oxyethylene) ethers.
Certain sensory modifiers are further desirable components in the compositions of the invention. Such materials are preferably used at a level of up to 20% by weight of a composition. Emollients, humectants, volatile oils, non-volatile oils, and particulate solids which impart lubricity are all suitable classes of sensory modifiers. Examples of such materials include cyclomethicone, dimethicone, dimethiconol, isopropyl myristate, isopropyl palmitate, talc, finely divided silica (e.g. Aerosil 200), polyethylene (eg. Acumist B18), polysaccharides, corn starch, C12-C15 alcohol benzoate, PPG-3 myristyl ether, octyl dodecanol, C7-C14 isoparaffins, di-isopropyl adipate, isosorbide laurate, PPG-14 butyl ether, glycerol, hydrogenated polyisobutene, polydecene, titanium dioxide, phenyl trimethicone, dioctyl adipate, and hexamethyl disiloxane.
It should be noted that certain components of compositions perform more than one function. Such components are particularly preferred additional ingredients, their use often saving both money and formulation space. Examples of such components include ethanol, isopropyl myristate, and silica. Further additional components that may also be included are colourants and preservatives, for example C1 -C3 alkyl parabens.
Aerosol compositions according to the invention generally comprise a volatile propellant. The level of incorporation of the volatile propellant is typically from 30 to 99 parts by weight and particularly from 50 to 95 parts by weight. Non- chlorinated volatile propellant are preferred, in particular liquefied hydrocarbons or halogenated hydrocarbon gases (particularly fluorinated hydrocarbons such as 1 , 1 -difluoroethane and/or 1 -trifluoro-2-fluoroethane) that have a boiling point of below 10°C and especially those with a boiling point below 0°C. It is especially preferred to employ liquefied hydrocarbon gases, and especially C3 to Ce hydrocarbons, including propane, isopropane, butane, isobutane, pentane and isopentane and mixtures of two or more thereof. Preferred propellants are isobutane, isobutane/isopropane, isobutane/propane and mixtures of isopropane, isobutane and butane.
Other propellants that can be contemplated include alkyl ethers, such as dimethyl ether or compressed non-reactive gases such as air, nitrogen or carbon dioxide. Compositions according to the invention may be prepared by suspending or dissolving the active in a cosmetically acceptable carrier material, preferably with sufficient agitation to achieve a homogeneous mixture. When the oxalysine is suspended in the carrier material, it is preferred that it is first ground to a mean particle size of less 100 microns. The fragrance material is preferably added to the composition after the oxalysine has been dissolved or suspended in the carrier.
In a third aspect there is provided the use of oxalysine for the prevention or reduction of malodour. In a fourth aspect there is provided the use of oxalysine as an antimicrobial agent. EXAMPLE Standard 5 & 24hr deodorancy test protocol was conducted.
A = Unfragranced ethanolic roll-on control
B = Unfragranced ethanolic roll-on + 0.3% Oxalysine 35 subjects participated in both the 5 hour and 24 hour tests.
Mean Malodour Score Mean Dosage (300mg)
5hr 24hr
A 2.23 2.42
B 2.36 2.54
Difference for significance @ 95% 0.09 0.10
Difference for significance @ 99% 0.12 0.13
At 5 hours: Oxalysine is superior to control with 99% confidence.
At 24 hours: Oxalysine is superior to control with 95% confidence.

Claims

1 . Composition comprising oxalysine.
2. Composition according to claim 1 wherein the oxalysine is present at from 0.001 to 1 .5% wt. of the composition.
3. Composition for reducing or prevent malodour comprising an effective antimicrobial amount of oxalysine.
4. Use of oxalysine for the prevention or reduction of malodour.
5. Use of oxalysine as an antimicrobial agent.
PCT/EP2011/062008 2010-07-28 2011-07-13 Composition WO2012013505A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171093.7 2010-07-28
EP10171093 2010-07-28

Publications (2)

Publication Number Publication Date
WO2012013505A2 true WO2012013505A2 (en) 2012-02-02
WO2012013505A3 WO2012013505A3 (en) 2012-03-22

Family

ID=43531841

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/062008 WO2012013505A2 (en) 2010-07-28 2011-07-13 Composition

Country Status (1)

Country Link
WO (1) WO2012013505A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021517125A (en) * 2018-03-07 2021-07-15 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションTemple University−Of The Commonwealth System Of Higher Education Compositions and Methods for Treating Insulin Resistance
WO2021162879A1 (en) * 2020-02-14 2021-08-19 Tranexamic Technologies, Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545556A2 (en) 1991-11-08 1993-06-09 Quest International Nederland Bv Perfume composition
EP1248520B1 (en) 2000-01-18 2003-08-06 Unilever Plc Anti-microbial compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3385800A (en) * 1999-03-01 2000-09-21 David Barnes Eukaryotic peptide uptake system for transportation of enkephalins
US20030161799A1 (en) * 2002-02-26 2003-08-28 Georgiy Borisovich Kuznetsov Practical and humane method for armpit odor care

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0545556A2 (en) 1991-11-08 1993-06-09 Quest International Nederland Bv Perfume composition
EP1248520B1 (en) 2000-01-18 2003-08-06 Unilever Plc Anti-microbial compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
S.A.MAKIN, M.R.LOWRY: "Antiperspirants and Deodorants", 1999, MARCEL DEKKER, article "Deodorant Ingredients"

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021517125A (en) * 2018-03-07 2021-07-15 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイションTemple University−Of The Commonwealth System Of Higher Education Compositions and Methods for Treating Insulin Resistance
WO2021162879A1 (en) * 2020-02-14 2021-08-19 Tranexamic Technologies, Llc Methods and compositions for antimicrobial use of synthetic lysine analogs, derivatives, mimetics, and prodrugs

Also Published As

Publication number Publication date
WO2012013505A3 (en) 2012-03-22

Similar Documents

Publication Publication Date Title
AU2002249104B2 (en) Antimicrobial deodorant compositions
US6616921B2 (en) Antiperspirant products
AU719400B2 (en) Deodorant compositions
US20010033854A1 (en) Anti-microbial compositions
US20090317345A1 (en) Antiperspirant/Deodorant Gel Composition With Low Pouring Temperature
US6509010B2 (en) Cosmetic products for the reduction of sweat acidity
EP1971320B1 (en) Antiperspirant compositions
AU744094B2 (en) Underarm cosmetic compositions with lower alkyl acetate
AU772448B2 (en) Anti-microbial antiperspirant products
EP2142258B1 (en) Cosmetic composition comprising an aluminium salt
AU2003206906B2 (en) Antiperspirant or deodorant composition
WO2012013505A2 (en) Composition
EP1883388B1 (en) Achieving a deodorising effect with aminoacid derivates
AU2002319216B9 (en) Cosmetic compositions
ES2926826T3 (en) Method to reduce perspiration
AU2015363613B2 (en) Antiperspirant compositions comprising alums
AU2002319216A1 (en) Cosmetic compositions
EP3493786B1 (en) Active agent and method for reducing malodor
WO2003002083A2 (en) Anhydrous liquid antiperspirant emulsions
MXPA01009117A (en) Cosmetic stick composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11730715

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11730715

Country of ref document: EP

Kind code of ref document: A2